Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Van Wijmeersch B, Singer BA, Boster A, Broadley S, et al. Efficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies. Mult Scler 2019 Nov 1:1352458519881759. doi: 10.1177/1352458519881759.
PMID: 31675266

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016